nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—HTR2B—cardial valve—dilated cardiomyopathy	0.182	0.575	CbGeAlD
Agomelatine—CYP2C9—cardial valve—dilated cardiomyopathy	0.118	0.373	CbGeAlD
Agomelatine—Encainide—SCN5A—dilated cardiomyopathy	0.035	1	CrCbGaD
Agomelatine—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.0247	0.0821	CcSEcCtD
Agomelatine—HTR2B—heart—dilated cardiomyopathy	0.01	0.0318	CbGeAlD
Agomelatine—Irritability—Furosemide—dilated cardiomyopathy	0.00712	0.0237	CcSEcCtD
Agomelatine—CYP2C9—heart—dilated cardiomyopathy	0.0065	0.0206	CbGeAlD
Agomelatine—Eczema—Lisinopril—dilated cardiomyopathy	0.00623	0.0207	CcSEcCtD
Agomelatine—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00623	0.0207	CcSEcCtD
Agomelatine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00599	0.0199	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00582	0.0194	CcSEcCtD
Agomelatine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00544	0.0181	CcSEcCtD
Agomelatine—Face oedema—Lisinopril—dilated cardiomyopathy	0.0054	0.018	CcSEcCtD
Agomelatine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00535	0.0178	CcSEcCtD
Agomelatine—Irritability—Lisinopril—dilated cardiomyopathy	0.00534	0.0178	CcSEcCtD
Agomelatine—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00501	0.0167	CcSEcCtD
Agomelatine—Influenza—Lisinopril—dilated cardiomyopathy	0.00484	0.0161	CcSEcCtD
Agomelatine—Eye disorder—Furosemide—dilated cardiomyopathy	0.00482	0.0161	CcSEcCtD
Agomelatine—Tinnitus—Furosemide—dilated cardiomyopathy	0.00481	0.016	CcSEcCtD
Agomelatine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00477	0.0159	CcSEcCtD
Agomelatine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00461	0.0153	CcSEcCtD
Agomelatine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00446	0.0148	CcSEcCtD
Agomelatine—Weight increased—Lisinopril—dilated cardiomyopathy	0.0044	0.0147	CcSEcCtD
Agomelatine—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00438	0.0146	CcSEcCtD
Agomelatine—Depression—Lisinopril—dilated cardiomyopathy	0.0043	0.0143	CcSEcCtD
Agomelatine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00429	0.0143	CcSEcCtD
Agomelatine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00423	0.0141	CcSEcCtD
Agomelatine—Headache—Spironolactone—dilated cardiomyopathy	0.00422	0.0141	CcSEcCtD
Agomelatine—Jaundice—Lisinopril—dilated cardiomyopathy	0.0042	0.014	CcSEcCtD
Agomelatine—Agitation—Furosemide—dilated cardiomyopathy	0.00413	0.0137	CcSEcCtD
Agomelatine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00408	0.0136	CcSEcCtD
Agomelatine—Vertigo—Furosemide—dilated cardiomyopathy	0.00404	0.0134	CcSEcCtD
Agomelatine—Nausea—Spironolactone—dilated cardiomyopathy	0.004	0.0133	CcSEcCtD
Agomelatine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00387	0.0129	CcSEcCtD
Agomelatine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00385	0.0128	CcSEcCtD
Agomelatine—MTNR1A—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00384	0.011	CbGpPWpGaD
Agomelatine—MTNR1B—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00383	0.011	CbGpPWpGaD
Agomelatine—MTNR1A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00383	0.011	CbGpPWpGaD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.0038	0.0126	CcSEcCtD
Agomelatine—HTR2C—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00377	0.0108	CbGpPWpGaD
Agomelatine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00374	0.0124	CcSEcCtD
Agomelatine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00361	0.012	CcSEcCtD
Agomelatine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.0036	0.012	CcSEcCtD
Agomelatine—HTR2B—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—RAF1—dilated cardiomyopathy	0.00359	0.0103	CbGpPWpGaD
Agomelatine—MTNR1A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00356	0.0102	CbGpPWpGaD
Agomelatine—MTNR1B—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00356	0.0102	CbGpPWpGaD
Agomelatine—Skin disorder—Furosemide—dilated cardiomyopathy	0.00356	0.0119	CcSEcCtD
Agomelatine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00354	0.0118	CcSEcCtD
Agomelatine—MTNR1A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00345	0.00989	CbGpPWpGaD
Agomelatine—MTNR1B—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00345	0.00989	CbGpPWpGaD
Agomelatine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00339	0.0113	CcSEcCtD
Agomelatine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00329	0.011	CcSEcCtD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00328	0.00941	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00328	0.00941	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00328	0.00941	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00328	0.00941	CbGpPWpGaD
Agomelatine—Back pain—Lisinopril—dilated cardiomyopathy	0.00326	0.0109	CcSEcCtD
Agomelatine—Somnolence—Furosemide—dilated cardiomyopathy	0.00326	0.0108	CcSEcCtD
Agomelatine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00318	0.0106	CcSEcCtD
Agomelatine—HTR2C—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00317	0.00909	CbGpPWpGaD
Agomelatine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00317	0.0105	CcSEcCtD
Agomelatine—Fatigue—Furosemide—dilated cardiomyopathy	0.00316	0.0105	CcSEcCtD
Agomelatine—Tremor—Lisinopril—dilated cardiomyopathy	0.00316	0.0105	CcSEcCtD
Agomelatine—Constipation—Furosemide—dilated cardiomyopathy	0.00314	0.0104	CcSEcCtD
Agomelatine—Angioedema—Lisinopril—dilated cardiomyopathy	0.00308	0.0103	CcSEcCtD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00305	0.00875	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00305	0.00875	CbGpPWpGaD
Agomelatine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00303	0.0101	CcSEcCtD
Agomelatine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.003	0.00998	CcSEcCtD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00296	0.00847	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00296	0.00847	CbGpPWpGaD
Agomelatine—MTNR1A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00295	0.00845	CbGpPWpGaD
Agomelatine—MTNR1B—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00295	0.00845	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00295	0.00844	CbGpPWpGaD
Agomelatine—Urticaria—Furosemide—dilated cardiomyopathy	0.00291	0.00969	CcSEcCtD
Agomelatine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—RAF1—dilated cardiomyopathy	0.0029	0.00831	CbGpPWpGaD
Agomelatine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.0029	0.00965	CcSEcCtD
Agomelatine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00286	0.00952	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00285	0.00949	CcSEcCtD
Agomelatine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00281	0.00934	CcSEcCtD
Agomelatine—MTNR1B—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.0028	0.00801	CbGpPWpGaD
Agomelatine—MTNR1A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.0028	0.00801	CbGpPWpGaD
Agomelatine—Infection—Lisinopril—dilated cardiomyopathy	0.00273	0.0091	CcSEcCtD
Agomelatine—MTNR1B—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.0027	0.00775	CbGpPWpGaD
Agomelatine—MTNR1A—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.0027	0.00775	CbGpPWpGaD
Agomelatine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00267	0.00889	CcSEcCtD
Agomelatine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00266	0.00885	CcSEcCtD
Agomelatine—Asthenia—Furosemide—dilated cardiomyopathy	0.00263	0.00876	CcSEcCtD
Agomelatine—Pruritus—Furosemide—dilated cardiomyopathy	0.00259	0.00863	CcSEcCtD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00252	0.00724	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00252	0.00724	CbGpPWpGaD
Agomelatine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00251	0.00835	CcSEcCtD
Agomelatine—MTNR1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.0025	0.00717	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.0025	0.00717	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.0025	0.00717	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.0025	0.00717	CbGpPWpGaD
Agomelatine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00249	0.00828	CcSEcCtD
Agomelatine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00247	0.00822	CcSEcCtD
Agomelatine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00245	0.00814	CcSEcCtD
Agomelatine—Dizziness—Furosemide—dilated cardiomyopathy	0.00242	0.00807	CcSEcCtD
Agomelatine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00242	0.00806	CcSEcCtD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00239	0.00687	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00239	0.00687	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00238	0.00681	CbGpPWpGaD
Agomelatine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00238	0.0079	CcSEcCtD
Agomelatine—Fatigue—Lisinopril—dilated cardiomyopathy	0.00237	0.00789	CcSEcCtD
Agomelatine—Constipation—Lisinopril—dilated cardiomyopathy	0.00235	0.00783	CcSEcCtD
Agomelatine—Vomiting—Furosemide—dilated cardiomyopathy	0.00233	0.00776	CcSEcCtD
Agomelatine—MTNR1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00232	0.00666	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00232	0.00666	CbGpPWpGaD
Agomelatine—Headache—Furosemide—dilated cardiomyopathy	0.0023	0.00764	CcSEcCtD
Agomelatine—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00225	0.00646	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00225	0.00645	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00225	0.00645	CbGpPWpGaD
Agomelatine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00225	0.00749	CcSEcCtD
Agomelatine—MTNR1A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00223	0.00641	CbGpPWpGaD
Agomelatine—MTNR1B—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00223	0.00641	CbGpPWpGaD
Agomelatine—Urticaria—Lisinopril—dilated cardiomyopathy	0.00219	0.00727	CcSEcCtD
Agomelatine—Nausea—Furosemide—dilated cardiomyopathy	0.00218	0.00725	CcSEcCtD
Agomelatine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00217	0.00724	CcSEcCtD
Agomelatine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00197	0.00657	CcSEcCtD
Agomelatine—Pruritus—Lisinopril—dilated cardiomyopathy	0.00195	0.00648	CcSEcCtD
Agomelatine—MTNR1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00192	0.00551	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00192	0.00551	CbGpPWpGaD
Agomelatine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00188	0.00626	CcSEcCtD
Agomelatine—MTNR1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00182	0.00523	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00182	0.00523	CbGpPWpGaD
Agomelatine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00182	0.00605	CcSEcCtD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00178	0.00509	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00178	0.00509	CbGpPWpGaD
Agomelatine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00175	0.00582	CcSEcCtD
Agomelatine—Headache—Lisinopril—dilated cardiomyopathy	0.00172	0.00574	CcSEcCtD
Agomelatine—Nausea—Lisinopril—dilated cardiomyopathy	0.00163	0.00544	CcSEcCtD
Agomelatine—MTNR1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00141	0.00405	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00141	0.00405	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00141	0.00405	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00141	0.00405	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00135	0.00388	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00135	0.00388	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00131	0.00377	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00131	0.00377	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00128	0.00368	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00128	0.00368	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00128	0.00368	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00128	0.00368	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00127	0.00365	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00127	0.00365	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00124	0.00355	CbGpPWpGaD
Agomelatine—HTR2B—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00123	0.00353	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00119	0.00342	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00119	0.00342	CbGpPWpGaD
Agomelatine—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00117	0.00335	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00116	0.00331	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00116	0.00331	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00115	0.0033	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00111	0.00319	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.0011	0.00316	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00109	0.00311	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00109	0.00311	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00106	0.00304	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00106	0.00304	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.00104	0.00298	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00103	0.00295	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00103	0.00295	CbGpPWpGaD
Agomelatine—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000998	0.00286	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000998	0.00286	CbGpPWpGaD
Agomelatine—HTR2C—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.000993	0.00285	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000987	0.00283	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000987	0.00283	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000985	0.00282	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000954	0.00274	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000951	0.00273	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000936	0.00268	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000936	0.00268	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000928	0.00266	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000902	0.00259	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000899	0.00258	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000888	0.00255	CbGpPWpGaD
Agomelatine—HTR2B—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000866	0.00248	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000855	0.00245	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000855	0.00245	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000854	0.00245	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000854	0.00245	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000815	0.00234	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000807	0.00231	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000807	0.00231	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.0008	0.00229	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.0008	0.00229	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000795	0.00228	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000774	0.00222	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000773	0.00222	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00077	0.00221	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000767	0.0022	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000764	0.00219	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000764	0.00219	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000758	0.00217	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000758	0.00217	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000758	0.00217	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000758	0.00217	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00075	0.00215	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000728	0.00209	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000727	0.00208	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000727	0.00208	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000727	0.00208	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000723	0.00207	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000705	0.00202	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000705	0.00202	CbGpPWpGaD
Agomelatine—HTR2C—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000699	0.002	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000694	0.00199	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000694	0.00199	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000682	0.00196	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000682	0.00196	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00068	0.00195	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000657	0.00188	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000651	0.00187	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000651	0.00187	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000649	0.00186	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000625	0.00179	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000624	0.00179	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000621	0.00178	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000618	0.00177	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000605	0.00174	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000589	0.00169	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000586	0.00168	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000583	0.00167	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000583	0.00167	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000581	0.00166	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000573	0.00164	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000553	0.00159	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000553	0.00159	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000537	0.00154	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000501	0.00144	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000482	0.00138	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000482	0.00138	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000475	0.00136	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000475	0.00136	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000475	0.00136	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000463	0.00133	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000456	0.00131	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000456	0.00131	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000445	0.00128	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000445	0.00128	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000437	0.00125	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000434	0.00124	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000429	0.00123	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000429	0.00123	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000424	0.00122	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000424	0.00122	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000424	0.00122	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000414	0.00119	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000414	0.00119	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000411	0.00118	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—AGT—dilated cardiomyopathy	0.00041	0.00118	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—AGT—dilated cardiomyopathy	0.00041	0.00118	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000385	0.0011	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000373	0.00107	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000369	0.00106	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000368	0.00105	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000368	0.00105	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000352	0.00101	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000351	0.00101	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000342	0.000981	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000334	0.000958	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000334	0.000958	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000333	0.000954	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000331	0.00095	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.00033	0.000947	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.00033	0.000947	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000322	0.000923	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000318	0.000913	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000311	0.000891	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	0.000303	0.000868	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000302	0.000866	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000301	0.000862	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000297	0.000852	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000285	0.000816	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000285	0.000816	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000283	0.000811	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000276	0.00079	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000275	0.000789	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	0.000274	0.000785	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000268	0.00077	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	0.000259	0.000741	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000258	0.000741	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000257	0.000737	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000247	0.000708	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000245	0.000701	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000245	0.000701	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000244	0.000699	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000235	0.000672	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	0.000234	0.00067	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000227	0.000652	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000224	0.000642	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000222	0.000637	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00022	0.000632	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000208	0.000597	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000199	0.000571	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000197	0.000566	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000197	0.000566	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000195	0.00056	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000195	0.00056	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000189	0.000543	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000188	0.000539	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000184	0.000526	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000181	0.000518	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000178	0.000512	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000178	0.00051	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000167	0.000479	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000163	0.000466	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000156	0.000446	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000153	0.00044	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000152	0.000435	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000146	0.00042	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000144	0.000413	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000143	0.000409	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000139	0.000398	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000139	0.000397	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000132	0.00038	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000125	0.00036	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000125	0.000359	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000124	0.000355	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000112	0.00032	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	0.000107	0.000306	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000107	0.000306	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—RAF1—dilated cardiomyopathy	9.19e-05	0.000263	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.6e-05	0.000247	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	7.43e-05	0.000213	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	7.41e-05	0.000213	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	7.24e-05	0.000208	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	6.52e-05	0.000187	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	6.35e-05	0.000182	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—EGFR—dilated cardiomyopathy	6.3e-05	0.000181	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	6.19e-05	0.000177	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	5.57e-05	0.00016	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	5.08e-05	0.000146	CbGpPWpGaD
